Shorena Janelidze

Targets

• APOE 1
• MAPT 1

Filled chips are declared by the researcher; the others come from publications (number of works).

Now

Trials, publications and grants since Nov 2024.

• Publication

  The tau biomarker cascade is condensed in Down syndrome compared with sporadic Alzheimer's disease.

  Brain : a journal of neurology, Jul 2026

• Publication

  Estimating the time course of biomarker changes in Alzheimer's disease.

  Brain : a journal of neurology, Jun 2026

• Publication

  Diagnostic Value of Serum p-tau217 in Alzheimer Disease: Equal to Plasma in Levels and Clinical Utility?

  Clinical chemistry, Feb 2026

• Publication

  Locus coeruleus-entorhinal cortex tract integrity is linked to plasma tau and glial fibrillary acidic protein.

  Alzheimer's & dementia : the journal of the Alzheimer's Association, Dec 2025

• Publication

  Prediction of continuous amyloid positron emission tomography with fluid measures of phosphorylated tau and β-amyloid.

  EMBO molecular medicine, Dec 2025

• Publication

  Characterizing the onset and progression of Alzheimer's pathologies using amyloid and tau PET imaging and plasma p-tau217.

  Brain communications, Nov 2025

• Publication

  CSF pTDP-43 across the Alzheimer's spectrum: Links to amyloid, APOE and vasculopathy.

  Neurobiology of disease, Nov 2025

• Publication

  A new blood biomarker for Alzheimer's disease.

  Nature medicine, Nov 2025

• Preprint

  P-TAU205 IS A BIOMARKER LINKED TO TAU-PET ABNORMALITY: A CROSS-SECTIONAL AND LONGITUDINAL STUDY.

  medRxiv : the preprint server for health sciences, Oct 2025

Affiliations

• Lund University

Co-authors

• RBRandall J BatemanHow are we linked?

Who links you

Enter another researcher's profile link or ID to see who has published with both of you.